Abstract
Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 02/02/2001, Revision: 24, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have